Renal Protective Effect of Everolimus in Liver Transplantation: A Prospective Randomized Open-Label Trial

Renal Protective Effect of Everolimus in Liver Transplantation: A Prospective Randomized Open-Label Trial

Background. Renal dysfunction is associated with poor long-term outcomes after liver transplantation. We examined the renal sparing effect of everolimus (EVR) compared to standard calcineurin inhibitor (CNI) immunosuppression with direct measurements of renal function over 24 months. Methods. This w...

Full description

Bibliographic Details
Main Authors: Zakiyah Kadry, MD, Jonathan G. Stine, MD, Takehiko Dohi, MD, Ashokkumar Jain, MD, Kimberly L. Robyak, BS, Osun Kwon, MD, Christopher J. Hamilton, BS, Piotr Janicki, MD, Thomas R. Riley, III, MD, Fauzia Butt, MD, Karen Krok, MD, Ian R. Schreibman, MD, Dmitri Bezinover, MD, Nasrollah Ghahramani, MD, Stalin Campos, MD, Christopher S. Hollenbeak, PhD
Format: Article
Language:English
Published: Wolters Kluwer 2021-07-01
Series:Transplantation Direct
Online Access:http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000001159

Internet

http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000001159

Similar Items